We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cronin | LSE:CRON | London | Ordinary Share | GB00B29YYY86 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | 3.10 | 3.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/5/2018 08:24 | New thread for DeepMatter (new name for Cronin) here: rrr | rrr | |
16/5/2018 18:22 | From tomorrow we're DeepMatter Group Plc. I will set up a new thread once ADVFN knows about it. "As a result, the Company confirms that as of 08:00 a.m. on 17 May 2018, its shares will trade under the new name DeepMatter Group Plc and the TIDM 'DMTR'. The Company confirms that there is no change to the Company's ISIN: GB00B29YYY86. The Company's new website will be available from 07:00 am on 17 May 2018 and can be found at www.deepmatter.io." rrr | rrr | |
16/5/2018 09:28 | AGM today. | rrr | |
28/4/2018 12:35 | Proposed change of name "It is proposed that, to better represent the mission and values of the Company, its name be changed to "DeepMatter Group Plc", as set out in resolution 7 of the attached Notice of Annual General Meeting to be held on 16 May 2018." f | fillipe | |
26/4/2018 21:52 | No revenues given so far, except FT article mentioned expecting revenues in 2019, which part of 2019 we don't know yet will feel more comfortable once a broker note is released, to further understand Cron's revenue from this business | euclid5 | |
26/4/2018 09:19 | Bid/ask as I type is 2.8p v 3.6p and from how I read it a sale has gone through at 2.9p, with a buy @ 3.5p. As ever, any sustained buying will see this move up a lot. I feel that's the most likely direction of travel at CRON. f | fillipe | |
25/4/2018 20:01 | The 1.418m trade at 2.60p looks priced as a sell, although could of been a worked buy order. As bid price was 2.20p & you could buy at 2.7p, so potentially a buy | euclid5 | |
25/4/2018 10:25 | 3.4p at the lowest ask on show - interest showing up at CRON this morning. f | fillipe | |
24/4/2018 17:37 | £10,000 director purchase is encouraging. | rrr | |
23/4/2018 09:54 | CRON - I read they are to be renamed "DeepMatter" - I rather like that and feel that in itself it will give a lift to the share price f | fillipe | |
21/4/2018 19:06 | Does anyone know the time frame of this trial ? "The purpose of the programme is to trial the Company's technology with the full range of target users, allowing the Company to observe its performance in different operating environments and locations worldwide" | euclid5 | |
21/4/2018 08:49 | Thank you - a renaming is coming I see. | rrr | |
21/4/2018 08:30 | https://app.ft.com/c | swashbuck1er | |
19/4/2018 14:54 | I do realise that, I'm hoping though! | rrr | |
19/4/2018 11:40 | Gaps don't always get filled rrr | jpuff | |
19/4/2018 09:11 | Good news. There's a gap to be filled at 2p so I'm hoping to buy some more there in time. | rrr | |
19/4/2018 08:54 | Further progress being made which is encouraging. | jpuff | |
12/4/2018 11:29 | Now you know... | rrr | |
10/4/2018 14:39 | Really quite active today - am unsure why, but CRON is almost +42%, as I type. f | fillipe | |
05/4/2018 19:39 | Yes, that's quite a decent sum to buy. | rrr | |
05/4/2018 18:03 | £10k's worth for the Prof. Clearly he regards the recent drop as an opportunity. | shrout | |
03/4/2018 16:24 | Post 55 would be a good place to look to get more idea. | rrr | |
05/3/2018 19:37 | I missed this re MoUs at the time (6/2/18): seems a good approach to development: | rrr | |
19/1/2018 18:20 | How long before someone prints a recipe for DIY MDMA or acid? Or personalised variants thereof? I could see a big market for this technology ;¬) | supernumerary |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions